Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

congress money medicare washington DC senate house

House lawmakers criticize Medicare pay model targeting ‘wasteful’ interventional radiology services

CMS is seeking to cut unnecessary use of certain IR services in Medicare, such as image-guided decompression of the spine, epidural steroid injections and percutaneous vertebral augmentation.  

Cook Medical

Cook Medical hopes new iMRI division could be ‘game changer’ for interventional radiology

The Bloomington, Indiana-based vendor is betting big on MRI's use in image-guided care, touting its ability to cut radiation exposure while bolstering precision. 

Conformal Medical CLAAS

Medtech company raises $32M for foam-based LAAO device

New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial. 

Thumbnail

ACR forms task force to explore corporatization and consolidation in radiology

“We need a common understanding of what is happening out there. As it stands now, we don’t have fundamental terms defined that are necessary to make informed plans and decisions," one rad says. 

blood pressure hypertension cuff

Medicare proposes paying for interventional radiology procedure to treat resistant hypertension

The Society of Interventional Radiology recently weighed in on the proposal, expressing concern about requirements to employ a "hypertension navigator." 

Heartflow president and CEO John Farquhar celebrate the company's IPO by ringing Nasdaq's the ceremonial opening bell.

Heartflow raises $364M with IPO, rings Nasdaq opening bell

Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.

Cardiac amyloidosis ATTR-CM drug promotion at the 2024 American Heart Association meeting.

High cost of cardiac amyloidosis drugs may limit access for low-income patients

"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.

Imaging groups urge Trump administration to exempt radiopharmaceuticals, medical isotopes from tariffs

Six physician professional associations recently made their case in a letter to Howard Lutnick, secretary of the U.S. Department of Commerce.